This study is testing if low doses of atropine ophthalmic solution eye drops can help adults with excessive watery eyes (epiphora). Researchers want to see if the drops reduce how often you experience watery eyes and what side effects, if any, you might have. They are comparing two different strengths of atropine (0.005% and 0.01%) to find out which works best. You might be able to join if you are 18 or older, have watery eyes that require wiping at least twice a day, and have good vision in at least one eye. The study aims to enroll 18 participants, but its current recruitment status is unclear.

Study design

This is an interventional study comparing two strengths of atropine ophthalmic solution in 18 participants.

What's involved

You will use the eye drops for one week, attend two clinic visits for checkups and eye tests, and receive a follow-up phone call about two weeks after starting.

Compensation

Not stated in the trial record.

Follow-up

You will receive a follow-up phone call about two weeks after starting the treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.